Upregulation of EGFR signaling is correlated with tumor stroma remodeling and tumor recurrence in FGFR1-driven breast cancer.
about
2D-QSAR and 3D-QSAR Analyses for EGFR Inhibitors.FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).Surgical margins in the veterinary cancer patient.A new mild hyperthermia device to treat vascular involvement in cancer surgery.FGFR inhibitor, AZD4547, impedes the stemness of mammary epithelial cells in the premalignant tissues of MMTV-ErbB2 transgenic miceUnraveling a tumor type-specific regulatory core underlying E2F1-mediated epithelial-mesenchymal transition to predict receptor protein signatures.Circulating microRNAs in patients with hormone receptor-positive, metastatic breast cancer treated with dovitinib.Generation of an in vitro 3D PDAC stroma rich spheroid model.HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2.Targeting tumour microenvironment by tyrosine kinase inhibitor.Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges.Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.FGFR1-Activated Translation of WNT Pathway Components with Structured 5' UTRs Is Vulnerable to Inhibition of EIF4A-Dependent Translation InitiationEstablishment and characterization of three stable Basal/HER2-positive breast cancer cell lines derived from Chinese breast carcinoma with identical missense mutations in the DNA-binding domain of TP53
P2860
Q33787022-1CFAF877-A113-46E4-B849-80BCA838A831Q36983860-0A8FEB1C-7D63-41DA-A8CF-76BE8125A903Q38757865-16D64D06-1B46-4264-B084-7C12BBA8D92AQ41198521-B07B253A-82C0-4F25-93DE-65EE9123DCA1Q41200574-830FD763-3AE0-4C26-B421-5F1C2339042AQ41243144-024C8316-AD7D-4B04-B73C-FEF2249E4A65Q42370321-220FB9CF-8D88-4999-805D-1A4DFBA1705CQ42678442-69333016-3344-459C-AC35-FF5C4639327FQ45992368-AA48B1AA-ACA2-46CD-A402-F0FF1C6FE963Q49887906-2D2C77FA-5A80-4C3C-BA1F-1EC209065673Q49887925-F9239CAB-1A7E-498D-A403-40697A82CCDFQ53777182-7B15B11A-AD02-4F80-A83F-B58CAE87F261Q57753454-26F6DE6D-0AC9-4674-98C7-E421EE902A94Q58770540-669DE2DD-9247-43D9-9B2E-EC6D2F4CA3EA
P2860
Upregulation of EGFR signaling is correlated with tumor stroma remodeling and tumor recurrence in FGFR1-driven breast cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Upregulation of EGFR signaling ...... in FGFR1-driven breast cancer.
@ast
Upregulation of EGFR signaling ...... in FGFR1-driven breast cancer.
@en
type
label
Upregulation of EGFR signaling ...... in FGFR1-driven breast cancer.
@ast
Upregulation of EGFR signaling ...... in FGFR1-driven breast cancer.
@en
prefLabel
Upregulation of EGFR signaling ...... in FGFR1-driven breast cancer.
@ast
Upregulation of EGFR signaling ...... in FGFR1-driven breast cancer.
@en
P2093
P2860
P1476
Upregulation of EGFR signaling ...... in FGFR1-driven breast cancer.
@en
P2093
Cristian Coarfa
Dean P Edwards
Jeffrey M Rosen
Kimal Rajapakshe
Qianxing Mo
Shixia Huang
Susan G Hilsenbeck
Thomas Welte
Xiang Zhang
P2860
P2888
P356
10.1186/S13058-015-0649-1
P577
2015-11-18T00:00:00Z
P5875
P6179
1052806217